메뉴 건너뛰기




Volumn 132, Issue 3, 2009, Pages 305-311

Monitoring immunosuppression with measures of NFAT decreases cancer incidence

Author keywords

Cancer; ; Immunomonitoring; Immunosuppression; ; Transplantation;

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; STEROID; TRANSCRIPTION FACTOR NFAT;

EID: 67651160356     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.03.520     Document Type: Short Survey
Times cited : (15)

References (56)
  • 1
    • 1142310583 scopus 로고    scopus 로고
    • Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A
    • Giese T., Zeier M., Schemmer P., Uhl W., Schoels M., Dengler T., Buechler M., and Meuer S. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation 77 3 (2004) 339-344
    • (2004) Transplantation , vol.77 , Issue.3 , pp. 339-344
    • Giese, T.1    Zeier, M.2    Schemmer, P.3    Uhl, W.4    Schoels, M.5    Dengler, T.6    Buechler, M.7    Meuer, S.8
  • 2
    • 4344653892 scopus 로고    scopus 로고
    • Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors
    • Giese T., Zeier M., and Meuer S. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors. Nephrol. Dial Transplant. 19 Suppl 4 (2004) IV55-IV60
    • (2004) Nephrol. Dial Transplant. , vol.19 , Issue.SUPPL. 4
    • Giese, T.1    Zeier, M.2    Meuer, S.3
  • 4
    • 40649117424 scopus 로고    scopus 로고
    • Cancers after renal transplantation
    • Wong G., and Chapman J.R. Cancers after renal transplantation. Transplant. Rev. (Orlando) 22 2 (2008) 141-149
    • (2008) Transplant. Rev. (Orlando) , vol.22 , Issue.2 , pp. 141-149
    • Wong, G.1    Chapman, J.R.2
  • 5
    • 67651197536 scopus 로고    scopus 로고
    • 2007 OPTN/SRTR Annual Report 1997-2006. HHS/HRSA/HSB/DOT.
    • 2007 OPTN/SRTR Annual Report 1997-2006. HHS/HRSA/HSB/DOT.
  • 6
    • 1442338509 scopus 로고    scopus 로고
    • Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era
    • Meier-Kriesche H.U., Schold J.D., Srinivas T.R., and Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. 4 3 (2004) 378-383
    • (2004) Am. J. Transplant. , vol.4 , Issue.3 , pp. 378-383
    • Meier-Kriesche, H.U.1    Schold, J.D.2    Srinivas, T.R.3    Kaplan, B.4
  • 8
    • 27644474482 scopus 로고    scopus 로고
    • Malignancy after transplantation
    • Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 Suppl. 2 (2005) S254-S264
    • (2005) Transplantation , vol.80 , Issue.SUPPL. 2
    • Buell, J.F.1    Gross, T.G.2    Woodle, E.S.3
  • 9
    • 34250179862 scopus 로고    scopus 로고
    • Malignancies in renal transplantation: an unmet medical need
    • Dantal J., and Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol. Dial Transplant. 22 Suppl. 1 (2007) i4-i10
    • (2007) Nephrol. Dial Transplant. , vol.22 , Issue.SUPPL. 1
    • Dantal, J.1    Pohanka, E.2
  • 11
    • 0037337675 scopus 로고    scopus 로고
    • Tumours after kidney transplantation
    • Lutz J., and Heemann U. Tumours after kidney transplantation. Curr. Opin. Urol. 13 2 (2003) 105-109
    • (2003) Curr. Opin. Urol. , vol.13 , Issue.2 , pp. 105-109
    • Lutz, J.1    Heemann, U.2
  • 13
    • 17844367860 scopus 로고    scopus 로고
    • De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population
    • Buell J.F., Papaconstantinou H.T., Skalow B., Hanaway M.J., Alloway R.R., and Woodle E.S. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant. Proc. 37 2 (2005) 960-961
    • (2005) Transplant. Proc. , vol.37 , Issue.2 , pp. 960-961
    • Buell, J.F.1    Papaconstantinou, H.T.2    Skalow, B.3    Hanaway, M.J.4    Alloway, R.R.5    Woodle, E.S.6
  • 14
    • 0032574187 scopus 로고    scopus 로고
    • Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
    • Dantal J., Hourmant M., Cantarovich D., Giral M., Blancho G., Dreno B., and Soulillou J.P. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 351 9103 (1998) 623-628
    • (1998) Lancet , vol.351 , Issue.9103 , pp. 623-628
    • Dantal, J.1    Hourmant, M.2    Cantarovich, D.3    Giral, M.4    Blancho, G.5    Dreno, B.6    Soulillou, J.P.7
  • 16
    • 48649090163 scopus 로고    scopus 로고
    • Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer
    • Basu A., Contreras A.G., Datta D., Flynn E., Zeng L., Cohen H.T., Briscoe D.M., and Pal S. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res. 68 14 (2008) 5689-5698
    • (2008) Cancer Res. , vol.68 , Issue.14 , pp. 5689-5698
    • Basu, A.1    Contreras, A.G.2    Datta, D.3    Flynn, E.4    Zeng, L.5    Cohen, H.T.6    Briscoe, D.M.7    Pal, S.8
  • 17
    • 33744457937 scopus 로고    scopus 로고
    • Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients
    • Opelz G., Naujokat C., Daniel V., Terness P., and Dohler B. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation 81 9 (2006) 1227-1233
    • (2006) Transplantation , vol.81 , Issue.9 , pp. 1227-1233
    • Opelz, G.1    Naujokat, C.2    Daniel, V.3    Terness, P.4    Dohler, B.5
  • 18
    • 2442668989 scopus 로고    scopus 로고
    • Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
    • Koehl G.E., Andrassy J., Guba M., et al. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 77 9 (2004) 1319-1326
    • (2004) Transplantation , vol.77 , Issue.9 , pp. 1319-1326
    • Koehl, G.E.1    Andrassy, J.2    Guba, M.3
  • 19
    • 34250156366 scopus 로고    scopus 로고
    • The role of proliferation signal inhibitors in post-transplant malignancies
    • Gutierrez-Dalmau A., and Campistol J.M. The role of proliferation signal inhibitors in post-transplant malignancies. Nephrol. Dial. Transplant. 22 Suppl. 1 (2007) i11-i16
    • (2007) Nephrol. Dial. Transplant. , vol.22 , Issue.SUPPL. 1
    • Gutierrez-Dalmau, A.1    Campistol, J.M.2
  • 20
    • 34250183832 scopus 로고    scopus 로고
    • Use of proliferation signal inhibitors in the management of post-transplant malignancies-clinical guidance
    • Campistol J.M., Albanell J., Arns W., et al. Use of proliferation signal inhibitors in the management of post-transplant malignancies-clinical guidance. Nephrol. Dial Transplant. 22 Suppl. 1 (2007) i36-i41
    • (2007) Nephrol. Dial Transplant. , vol.22 , Issue.SUPPL. 1
    • Campistol, J.M.1    Albanell, J.2    Arns, W.3
  • 21
    • 20144367584 scopus 로고    scopus 로고
    • Sirolimus for Kaposi's sarcoma in renal-transplant recipients
    • Stallone G., Schena A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N. Engl. J. Med. 352 13 (2005) 1317-1323
    • (2005) N. Engl. J. Med. , vol.352 , Issue.13 , pp. 1317-1323
    • Stallone, G.1    Schena, A.2    Infante, B.3
  • 22
    • 33746488875 scopus 로고    scopus 로고
    • Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?
    • Di Paolo S., Teutonico A., Leogrande D., Capobianco C., and Schena P.F. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?. J. Am. Soc. Nephrol. 17 8 (2006) 2236-2244
    • (2006) J. Am. Soc. Nephrol. , vol.17 , Issue.8 , pp. 2236-2244
    • Di Paolo, S.1    Teutonico, A.2    Leogrande, D.3    Capobianco, C.4    Schena, P.F.5
  • 23
    • 34147104488 scopus 로고    scopus 로고
    • AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells
    • Frost P., Shi Y., Hoang B., and Lichtenstein A. AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells. Oncogene 26 16 (2007) 2255-2262
    • (2007) Oncogene , vol.26 , Issue.16 , pp. 2255-2262
    • Frost, P.1    Shi, Y.2    Hoang, B.3    Lichtenstein, A.4
  • 25
    • 13944269599 scopus 로고    scopus 로고
    • Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition
    • Goudar R.K., Shi Q., Hjelmeland M.D., et al. Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. Mol. Cancer Ther. 4 1 (2005) 101-112
    • (2005) Mol. Cancer Ther. , vol.4 , Issue.1 , pp. 101-112
    • Goudar, R.K.1    Shi, Q.2    Hjelmeland, M.D.3
  • 26
    • 10244229652 scopus 로고    scopus 로고
    • In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model
    • Frost P., Moatamed F., Hoang B., Shi Y., Gera J., Yan H., Gibbons J., and Lichtenstein A. In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model. Blood 104 13 (2004) 4181-4187
    • (2004) Blood , vol.104 , Issue.13 , pp. 4181-4187
    • Frost, P.1    Moatamed, F.2    Hoang, B.3    Shi, Y.4    Gera, J.5    Yan, H.6    Gibbons, J.7    Lichtenstein, A.8
  • 27
    • 27644436740 scopus 로고    scopus 로고
    • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
    • Kauffman H.M., Cherikh W.S., Cheng Y., Hanto D.W., and Kahan B.D. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80 7 (2005) 883-889
    • (2005) Transplantation , vol.80 , Issue.7 , pp. 883-889
    • Kauffman, H.M.1    Cherikh, W.S.2    Cheng, Y.3    Hanto, D.W.4    Kahan, B.D.5
  • 28
    • 33645458234 scopus 로고    scopus 로고
    • Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
    • Campistol J.M., Eris J., Oberbauer R., et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J. Am. Soc. Nephrol. 17 2 (2006) 581-589
    • (2006) J. Am. Soc. Nephrol. , vol.17 , Issue.2 , pp. 581-589
    • Campistol, J.M.1    Eris, J.2    Oberbauer, R.3
  • 29
    • 34250156714 scopus 로고    scopus 로고
    • Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors
    • Pascual J. Post-transplant lymphoproliferative disorder-the potential of proliferation signal inhibitors. Nephrol. Dial Transplant. 22 Suppl. 1 (2007) i27-i35
    • (2007) Nephrol. Dial Transplant. , vol.22 , Issue.SUPPL. 1
    • Pascual, J.1
  • 30
    • 37349034394 scopus 로고    scopus 로고
    • Reduced exposure to calcineurin inhibitors in renal transplantation
    • Ekberg H., Tedesco-Silva H., Demirbas A., et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N. Engl. J. Med. 357 25 (2007) 2562-2575
    • (2007) N. Engl. J. Med. , vol.357 , Issue.25 , pp. 2562-2575
    • Ekberg, H.1    Tedesco-Silva, H.2    Demirbas, A.3
  • 32
    • 0014702156 scopus 로고
    • Transplanted carcinoma in an immunosuppressed patient
    • Matter B., Zukoski C.F., Killen D.A., and Ginn E. Transplanted carcinoma in an immunosuppressed patient. Transplantation 9 1 (1970) 71-74
    • (1970) Transplantation , vol.9 , Issue.1 , pp. 71-74
    • Matter, B.1    Zukoski, C.F.2    Killen, D.A.3    Ginn, E.4
  • 33
    • 23944489274 scopus 로고    scopus 로고
    • Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft
    • Morath C., Rohmeiss P., Schwenger V., et al. Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 80 4 (2005) 540-542
    • (2005) Transplantation , vol.80 , Issue.4 , pp. 540-542
    • Morath, C.1    Rohmeiss, P.2    Schwenger, V.3
  • 34
    • 0021349053 scopus 로고
    • Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
    • Starzl T.E., Nalesnik M.A., Porter K.A., et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1 8377 (1984) 583-587
    • (1984) Lancet , vol.1 , Issue.8377 , pp. 583-587
    • Starzl, T.E.1    Nalesnik, M.A.2    Porter, K.A.3
  • 35
    • 0023597816 scopus 로고
    • Disseminated Kaposi's sarcoma-full regression after withdrawal of immunosuppressive therapy: report of a case
    • Wijnveen A.C., Persson H., Bjorck S., and Blohme I. Disseminated Kaposi's sarcoma-full regression after withdrawal of immunosuppressive therapy: report of a case. Transplant. Proc. 19 5 (1987) 3735-3736
    • (1987) Transplant. Proc. , vol.19 , Issue.5 , pp. 3735-3736
    • Wijnveen, A.C.1    Persson, H.2    Bjorck, S.3    Blohme, I.4
  • 36
    • 0036097712 scopus 로고    scopus 로고
    • Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression
    • Duman S., Toz H., Asci G., et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol. Dial Transplant. 17 5 (2002) 892-896
    • (2002) Nephrol. Dial Transplant. , vol.17 , Issue.5 , pp. 892-896
    • Duman, S.1    Toz, H.2    Asci, G.3
  • 37
    • 0037096705 scopus 로고    scopus 로고
    • Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine
    • Friedlaender M.M., Rubinger D., Rosenbaum E., Amir G., and Siguencia E. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 73 11 (2002) 1849-1850
    • (2002) Transplantation , vol.73 , Issue.11 , pp. 1849-1850
    • Friedlaender, M.M.1    Rubinger, D.2    Rosenbaum, E.3    Amir, G.4    Siguencia, E.5
  • 38
    • 0035051159 scopus 로고    scopus 로고
    • Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants
    • Otley C.C., Coldiron B.M., Stasko T., and Goldman G.D. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch. Dermatol. 137 4 (2001) 459-463
    • (2001) Arch. Dermatol. , vol.137 , Issue.4 , pp. 459-463
    • Otley, C.C.1    Coldiron, B.M.2    Stasko, T.3    Goldman, G.D.4
  • 39
    • 0029989141 scopus 로고    scopus 로고
    • Increasing transplant cancer patient survival by conversion of immunosuppressive agents
    • Chuang F.R., Hsieh H., Hsu K.T., and Huang H.F. Increasing transplant cancer patient survival by conversion of immunosuppressive agents. Transplant. Proc. 28 3 (1996) 1346-1347
    • (1996) Transplant. Proc. , vol.28 , Issue.3 , pp. 1346-1347
    • Chuang, F.R.1    Hsieh, H.2    Hsu, K.T.3    Huang, H.F.4
  • 40
    • 0024976004 scopus 로고
    • Cyclosporine
    • Kahan B.D. Cyclosporine. N. Engl. J. Med. 321 25 (1989) 1725-1738
    • (1989) N. Engl. J. Med. , vol.321 , Issue.25 , pp. 1725-1738
    • Kahan, B.D.1
  • 41
    • 0029789453 scopus 로고    scopus 로고
    • Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection
    • Kahan B.D., Welsh M., Schoenberg L., Rutzky L.P., Katz S.M., Urbauer D.L., and Van Buren C.T. Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 62 5 (1996) 599-606
    • (1996) Transplantation , vol.62 , Issue.5 , pp. 599-606
    • Kahan, B.D.1    Welsh, M.2    Schoenberg, L.3    Rutzky, L.P.4    Katz, S.M.5    Urbauer, D.L.6    Van Buren, C.T.7
  • 42
    • 0036334289 scopus 로고    scopus 로고
    • Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month
    • Morris R.G., Russ G.R., Cervelli M.J., Juneja R., McDonald S.P., and Mathew T.H. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther. Drug Monit. 24 4 (2002) 479-486
    • (2002) Ther. Drug Monit. , vol.24 , Issue.4 , pp. 479-486
    • Morris, R.G.1    Russ, G.R.2    Cervelli, M.J.3    Juneja, R.4    McDonald, S.P.5    Mathew, T.H.6
  • 43
    • 0036150427 scopus 로고    scopus 로고
    • Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?
    • Oellerich M., and Armstrong V.W. Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy?. Ther. Drug Monit. 24 1 (2002) 40-46
    • (2002) Ther. Drug Monit. , vol.24 , Issue.1 , pp. 40-46
    • Oellerich, M.1    Armstrong, V.W.2
  • 44
    • 0141768209 scopus 로고    scopus 로고
    • Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion
    • Thervet E., Pfeffer P., Scolari M.P., et al. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Transplantation 76 6 (2003) 903-908
    • (2003) Transplantation , vol.76 , Issue.6 , pp. 903-908
    • Thervet, E.1    Pfeffer, P.2    Scolari, M.P.3
  • 45
    • 0242300598 scopus 로고    scopus 로고
    • C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
    • Midtvedt K., Fauchald P., Bergan S., et al. C2 monitoring in maintenance renal transplant recipients: is it worthwhile?. Transplantation 76 8 (2003) 1236-1238
    • (2003) Transplantation , vol.76 , Issue.8 , pp. 1236-1238
    • Midtvedt, K.1    Fauchald, P.2    Bergan, S.3
  • 47
    • 33751531164 scopus 로고    scopus 로고
    • Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies
    • Sommerer C., Konstandin M., Dengler T., Schmidt J., Meuer S., Zeier M., and Giese T. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation 82 10 (2006) 1280-1285
    • (2006) Transplantation , vol.82 , Issue.10 , pp. 1280-1285
    • Sommerer, C.1    Konstandin, M.2    Dengler, T.3    Schmidt, J.4    Meuer, S.5    Zeier, M.6    Giese, T.7
  • 48
    • 0032846279 scopus 로고    scopus 로고
    • Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect
    • Stein C.M., Murray J.J., and Wood A.J. Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect. Clin. Chem. 45 9 (1999) 1477-1484
    • (1999) Clin. Chem. , vol.45 , Issue.9 , pp. 1477-1484
    • Stein, C.M.1    Murray, J.J.2    Wood, A.J.3
  • 49
    • 0036893274 scopus 로고    scopus 로고
    • Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression
    • Hartel C., Fricke L., Schumacher N., Kirchner H., and Muller-Steinhardt M. Delayed cytokine mRNA expression kinetics after T-lymphocyte costimulation: a quantitative measure of the efficacy of cyclosporin A-based immunosuppression. Clin. Chem. 48 12 (2002) 2225-2231
    • (2002) Clin. Chem. , vol.48 , Issue.12 , pp. 2225-2231
    • Hartel, C.1    Fricke, L.2    Schumacher, N.3    Kirchner, H.4    Muller-Steinhardt, M.5
  • 50
    • 0033571210 scopus 로고    scopus 로고
    • The temporal profile of calcineurin inhibition by cyclosporine in vivo
    • Halloran P.F., Helms L.M., Kung L., and Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 68 9 (1999) 1356-1361
    • (1999) Transplantation , vol.68 , Issue.9 , pp. 1356-1361
    • Halloran, P.F.1    Helms, L.M.2    Kung, L.3    Noujaim, J.4
  • 51
    • 40449093233 scopus 로고    scopus 로고
    • Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies
    • van Rossum H.H., Romijn F.P., Sellar K.J., Smit N.P., van der Boog P.J., de Fijter J.W., and van Pelt J. Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies. Clin. Chem. 54 3 (2008) 517-524
    • (2008) Clin. Chem. , vol.54 , Issue.3 , pp. 517-524
    • van Rossum, H.H.1    Romijn, F.P.2    Sellar, K.J.3    Smit, N.P.4    van der Boog, P.J.5    de Fijter, J.W.6    van Pelt, J.7
  • 52
    • 0034052928 scopus 로고    scopus 로고
    • Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP
    • Sottong P.R., Rosebrock J.A., Britz J.A., and Kramer T.R. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin. Diagn. Lab. Immunol. 7 2 (2000) 307-311
    • (2000) Clin. Diagn. Lab. Immunol. , vol.7 , Issue.2 , pp. 307-311
    • Sottong, P.R.1    Rosebrock, J.A.2    Britz, J.A.3    Kramer, T.R.4
  • 53
    • 34249990018 scopus 로고    scopus 로고
    • The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich
    • Wimmer C.D., Rentsch M., Crispin A., Illner W.D., Arbogast H., Graeb C., Jauch K.W., and Guba M. The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 71 12 (2007) 1271-1278
    • (2007) Kidney Int. , vol.71 , Issue.12 , pp. 1271-1278
    • Wimmer, C.D.1    Rentsch, M.2    Crispin, A.3    Illner, W.D.4    Arbogast, H.5    Graeb, C.6    Jauch, K.W.7    Guba, M.8
  • 54
    • 52649095428 scopus 로고    scopus 로고
    • Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients
    • Sommerer C., Hartschuh W., Enk A., Meuer S., Zeier M., and Giese T. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients. Clin. Transplant. 22 5 (2008) 549-554
    • (2008) Clin. Transplant. , vol.22 , Issue.5 , pp. 549-554
    • Sommerer, C.1    Hartschuh, W.2    Enk, A.3    Meuer, S.4    Zeier, M.5    Giese, T.6
  • 55
    • 38149059079 scopus 로고    scopus 로고
    • Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression
    • Sommerer C., Giese T., Schmidt J., Meuer S., and Zeier M. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Transplantation 85 1 (2008) 15-21
    • (2008) Transplantation , vol.85 , Issue.1 , pp. 15-21
    • Sommerer, C.1    Giese, T.2    Schmidt, J.3    Meuer, S.4    Zeier, M.5
  • 56
    • 67651167360 scopus 로고    scopus 로고
    • http://www.ctstransplant.org/.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.